M. J. V. van Campenhout

发表

Bachmann’s Bundle: A Key Player in the Development of Atrial Fibrillation?

M. Allessie, S. Ho, N. D. de Groot, 2013, Circulation. Arrhythmia and electrophysiology.

Hepatitis B virus RNA as Early Predictor for Response to PEGylated Interferon Alfa in HBeAg Negative Chronic Hepatitis B.

T. Berg, A. Boonstra, H. Janssen, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Machine-learning based patient classification using Hepatitis B virus full-length genome quasispecies from Asian and European cohorts

C. Boucher, T. Racek, F. García-Alcalde, 2019, Scientific Reports.

Development and validation of a model for hepatitis B e antigen seroconversion in entecavir‐treated patients with chronic hepatitis B

A. Boonstra, Jian Sun, Xieer Liang, 2019, Journal of medical virology.

Relationship between hepatitis B core‐related antigen levels and sustained HBeAg seroconversion in patients treated with nucleo(s)tide analogues

R. D. de Man, R. D. de Knegt, A. Boonstra, 2019, Journal of viral hepatitis.

Long‐term follow‐up of patients treated with entecavir and peginterferon add‐on therapy for HBeAg‐positive chronic hepatitis B infection: ARES long‐term follow‐up

K. Simon, R. Idilman, R. D. de Knegt, 2018, Journal of viral hepatitis.

Assay for Hepatitis B Core-related Antigen Identify Patients With High Viral Load: Systematic Review and Meta-analysis of Individual Participant Data.

M. Buti, M. Honda, Hwai I. Yang, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Low hepatitis B surface antigen and HBV DNA levels predict response to the addition of pegylated interferon to entecavir in hepatitis B e antigen positive chronic hepatitis B

H. Janssen, Liang Chen, B. Hansen, 2019, Alimentary Pharmacology and Therapeutics.

Hepatitis B virus RNA decline without concomitant viral antigen decrease is associated with a low probability of sustained response and hepatitis B surface antigen loss

T. Berg, R. D. de Man, R. D. de Knegt, 2020, Alimentary pharmacology & therapeutics.

Host and viral factors associated with serum hepatitis B virus RNA levels among patients in need for treatment

T. Berg, A. Boonstra, H. Janssen, 2018, Hepatology.

R. D. de Knegt, A. Boonstra, H. Janssen, 2016, Antiviral research.

Diagnostic and analytical performance of the hepatitis B core related antigen immunoassay in hepatitis B patients.

R. D. de Knegt, A. Boonstra, C. Geurtsvankessel, 2019, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Hepatitis B core-related antigen levels are associated with response to entecavir and peginterferon add-on therapy in hepatitis B e antigen-positive chronic hepatitis B patients.

N. Zhang, R. D. de Knegt, A. Boonstra, 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

CMV Primary Infection Is Associated With Donor‐Specific T Cell Hyporesponsiveness and Fewer Late Acute Rejections After Liver Transplantation

S. Mancham, J. Kwekkeboom, H. Metselaar, 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

CMV Primary Infection Is Associated With Donor‐Specific T Cell Hyporesponsiveness and Fewer Late Acute Rejections After Liver Transplantation

S. Mancham, J. Kwekkeboom, H. Metselaar, 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Ultra long-term follow-up of interferon-alpha treatment for HBeAg-positive chronic hepatitis B virus infection.

R. D. de Knegt, H. Janssen, B. Hansen, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.